{"id":62172,"date":"2023-07-04T10:40:53","date_gmt":"2023-07-04T05:10:53","guid":{"rendered":"http:\/\/finservwealth.com\/biocon-biologics-introduces-hulio-a-humira-biosimilar-for-rheumatoid-arthritis-in-us\/"},"modified":"2023-07-04T10:40:53","modified_gmt":"2023-07-04T05:10:53","slug":"biocon-biologics-introduces-hulio-a-humira-biosimilar-for-rheumatoid-arthritis-in-us","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/biocon-biologics-introduces-hulio-a-humira-biosimilar-for-rheumatoid-arthritis-in-us\/","title":{"rendered":"Biocon Biologics introduces Hulio, a Humira biosimilar for rheumatoid arthritis, in US"},"content":{"rendered":"<p> The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.<\/p><div id=\"finse-1673908497\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-biologics-introduces-huliohumira-biosimilar-for-rheumatoid-arthritisus_17101291.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said. The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-biologics-introduces-huliohumira-biosimilar-for-rheumatoid-arthritisus_17101291.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-biologics-introduces-huliohumira-biosimilar-for-rheumatoid-arthritisus_17101291.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said. The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-biologics-introduces-huliohumira-biosimilar-for-rheumatoid-arthritisus_17101291.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-62172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/v\/vaccine-injection_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/62172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=62172"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/62172\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=62172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=62172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=62172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}